Case 1: Adjuvant Therapy for Residual Disease in HER2+ Breast Cancer

Breast Cancer | Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative ...Подробнее

HER2 In Breast Cancer: Testing Guidelines and New Treatment ApproachesПодробнее

Adjuvant therapy for Early Stage Lung Cancer – Case Based Discussion for Patient with Stage 1B NSCLCПодробнее

Abstracting Stomach Cancer - CTR Coding Break (September 2023)Подробнее

Adjuvant Therapy | 2023 Best of Breast ConferenceПодробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

Imaging of neo adjuvant therapy in breast cancer treatmentПодробнее

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of BenefitПодробнее

2020 Evolution | Breast Cancer Case PresentationПодробнее

Advances in HER2-positive and HER2-low Breast CancerПодробнее

Case 1: Clinical Trials in Early-Stage HER2+ Breast CancerПодробнее

Case Review: T-DM1 for Residual HER2+ Breast CancerПодробнее